2012
DOI: 10.1016/j.exer.2012.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Thrombin stimulates stress fiber assembly in RPE cells by PKC/CPI-17-mediated MLCP inactivation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 67 publications
1
5
0
Order By: Relevance
“…We also found that thrombin-induced Ca 2+ sensitization was inhibited by GF-109203X, suggesting that thrombin activates the PKC pathway in SMCs of the small airways. This notion is supported by a recent study showing that proteinase-activated receptor 1 stimulation with thrombin results in PKC activation, CPI-17 phosphorylation, inhibition of MLCP, and rMLC phosphorylation during assembly and contraction of stress fibers in retinal pigment epithelium (Ruiz-Loredo et al, 2012).…”
Section: Pkc Activation Induces Small Airway Smc Twitchingsupporting
confidence: 71%
See 1 more Smart Citation
“…We also found that thrombin-induced Ca 2+ sensitization was inhibited by GF-109203X, suggesting that thrombin activates the PKC pathway in SMCs of the small airways. This notion is supported by a recent study showing that proteinase-activated receptor 1 stimulation with thrombin results in PKC activation, CPI-17 phosphorylation, inhibition of MLCP, and rMLC phosphorylation during assembly and contraction of stress fibers in retinal pigment epithelium (Ruiz-Loredo et al, 2012).…”
Section: Pkc Activation Induces Small Airway Smc Twitchingsupporting
confidence: 71%
“…Thrombin induces Ca 2+ sensitization of the contraction mediated by stress fibers in retinal pigment epithelial cells by activating PKC and thereby promoting phosphorylation of PKC-potentiated PP1 inhibitory protein of 17 kD (CPI-17) and rMLC (Ruiz-Loredo et al, 2012). Here, we investigated the role of PKC in small airway contraction by characterizing its contribution to: (a) the contractile response, (b) Ca 2+ signaling in SMCs, (c) changes in SMC Ca 2+ sensitivity, and (d) the cellular mechanisms underlying Ca 2+ oscillations and Ca 2+ sensitization.…”
Section: Introductionmentioning
confidence: 99%
“…1 A). The concentration of Y-27632 was chosen based on the work of Ruiz-Loredo et al which utilized a similar stress fiber disrupting property of the inhibitor 45 . The cited work used 0.5, 1 and 5 µM of the inhibitor; however, we found that employing 2 μM of the inhibitor was sufficient to dissolve stress fibers, while at this concentration we could minimize the aspecific effects of the inhibitor.…”
Section: Resultsmentioning
confidence: 99%
“…It is a PKC-activated phosphatase inhibitor with a relative molecular weight of 17 kDa, and is widely expressed in vascular and visceral smooth muscle cells ( 11 ). Studies have demonstrated that PKC phosphorylates CPI-17 at Thr-38, then phosphorylated CPI-17 binds with the 38 kDa MLCP catalytic subunit (the main unit responsible for enzymatic activity), which causes a 1,000-fold inhibition of MLCP, thus increasing calcium sensitivity and smooth muscle contraction ( 12 14 ). Additionally, nitric oxide (NO) binds with soluble guanylate cyclase in smooth muscle cells, which increases cyclic guanosine monophosphate (cGMP) levels; this activates a cGMP-dependent kinase, which then dephosphorylates CPI-17 and inhibits the calcium sensitization mediated by phosphorylated CPI-17; thus, this pathway reduces the Ca 2+ sensitivity of smooth muscle cells ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
“…The PKC/PKC-potentiated phosphatase inhibitor protein of 17 kDa (CPI-17) signaling pathway serves a critical role in the calcium sensitization of smooth muscle. CPI-17, a key substrate of PKC, is a PKC-dependent phosphatase inhibitor that inhibits the enzymatic activity of myosin light chain phosphatase (MLCP) ( 14 , 15 ). Su et al ( 16 ) silenced CPI-17 gene expression in bronchial smooth muscle using RNA interference technology, which decreased bronchial smooth muscle calcium sensitization, contraction frequency and contractility, suggesting that CPI-17 affects the contraction of smooth muscle.…”
Section: Introductionmentioning
confidence: 99%